Positions

Selected Publications

Academic Article

Year Title Altmetric
2019 Akkermansia muciniphila is permissive to arthritis in the K/BxN mouse model of arthritis.Genes and Immunity.  20:158-166. 2019
2018 Rituximab treatment for chronic steroid-dependent Henoch-Schonlein purpura: 8 cases and a review of the literature.Pediatric Rheumatology.  16:71. 2018
2018 Pediatric ocular lichen planus and lichen planopilaris: One new case and a review of the literature.Pediatric Dermatology.  35:859-863. 2018
2018 Risk Factors for Intraarticular Heterotopic Bone Formation in the Temporomandibular Joint in Juvenile Idiopathic Arthritis.Journal of Rheumatology.  45:1301-1307. 2018
2018 Juvenile Psoriatic Arthritis: A Report from the GRAPPA 2017 Annual Meeting.Journal of Rheumatology -Supplement-.  94:11-16. 2018
2018 Temporomandibular joint arthritis in juvenile idiopathic arthritis, now what?Pediatric Rheumatology.  16:32. 2018
2018 Pediatric rheumatology infusion center: report on therapeutic protocols and infusions given over 4 Years with focus on adverse events over 1 Year.Pediatric Rheumatology.  16:16. 2018
2018 Adiposity in Juvenile Psoriatic Arthritis.Journal of Rheumatology.  45:411-418. 2018
2018 Age and fecal microbial strain-specific differences in patients with spondyloarthritis.Arthritis Research.  20:14. 2018
2018 Defining the normal appearance of the temporomandibular joints by magnetic resonance imaging with contrast: a comparative study of children with and without juvenile idiopathic arthritis.Pediatric Rheumatology.  16:8. 2018
2017 Risk of tuberculosis among Alabama children and adolescents treated with tumor necrosis factor inhibitors: a retrospective study.Pediatric Rheumatology.  15:79. 2017
2017 Isolated Arthritis of the Temporomandibular Joint as the Initial Manifestation of Juvenile Idiopathic Arthritis.Journal of Rheumatology.  44:1632-1635. 2017
2017 Association of Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Autoantibodies With DRB1*07:01 and Severe Myositis in Juvenile Myositis Patients.Arthritis Care and Research.  69:1088-1094. 2017
2017 Biologic therapies for refractory juvenile dermatomyositis: five years of experience of the Childhood Arthritis and Rheumatology Research Alliance in North America.Pediatric Rheumatology.  15:50. 2017
2017 The Juvenile Psoriatic Arthritis Cohort in the CARRA Registry: Clinical Characteristics, Classification, and Outcomes.Journal of Rheumatology.  44:342-351. 2017
2017 Impact of genistein on the gut microbiome of humanized mice and its role in breast tumor inhibition.PLoS ONE.  12:e0189756. 2017
2016 Fecal metabolomics in pediatric spondyloarthritis implicate decreased metabolic diversity and altered tryptophan metabolism as pathogenic factors.Genes and Immunity.  17:400-405. 2016
2016 The microbiota in pediatric rheumatic disease: epiphenomenon or therapeutic target?Current Opinion in Rheumatology.  28:537-543. 2016
2016 Ustekinumab as a Therapeutic Option for Children With Refractory Enthesitis-Related Arthritis.JCR: Journal of Clinical Rheumatology.  22:282-284. 2016
2016 Gut microbiota-host interactions and juvenile idiopathic arthritis.Pediatric Rheumatology.  14:44. 2016
2015 Magnetic Resonance Imaging Findings following Intraarticular Infliximab Therapy for Refractory Temporomandibular Joint Arthritis among Children with Juvenile Idiopathic Arthritis.Journal of Rheumatology.  42:2155-2159. 2015
2015 Gut microbes, immunity, and spondyloarthritis.Clinical Immunology.  159:134-142. 2015
2015 Novel method to collect medication adverse events in juvenile arthritis: results from the childhood arthritis and rheumatology research alliance enhanced drug safety surveillance project.Arthritis Care and Research.  67:529-537. 2015
2015 Safety and efficacy of rituximab in childhood-onset systemic lupus erythematosus and other rheumatic diseases.Journal of Rheumatology.  42:541-546. 2015
2015 Systemic and intra-articular anti-inflammatory therapy of temporomandibular joint arthritis in children with juvenile idiopathic arthritisSeminars in Orthodontics.  21:125-133. 2015
2015 Temporomandibular joint arthritis in juvenile idiopathic arthritis: The last frontierInternational Journal of Clinical Rheumatology.  10:273-285. 2015
2014 Altered microbiota associated with abnormal humoral immune responses to commensal organisms in enthesitis-related arthritis.Arthritis Research.  16:486. 2014
2014 Adding canakinumab to the Childhood Arthritis and Rheumatology Research Alliance consensus treatment plans for systemic juvenile idiopathic arthritis: Comment on the article by DeWitt et al.Arthritis Care and Research.  66:1430-1431. 2014
2014 Imaging of the temporomandibular joint in juvenile idiopathic arthritis.Arthritis Care and Research.  66:47-54. 2014
2014 Treatment of juvenile idiopathic arthritis: a revolution in care.Pediatric Rheumatology.  12:13. 2014
2013 Treatment of juvenile idiopathic arthritis in the biologic age.Rheumatic Disease Clinics of North America.  39:751-766. 2013
2013 High doses of infliximab in the management of juvenile idiopathic arthritis.Journal of Rheumatology.  40:1749-1755. 2013
2013 Safety and efficacy of intra-articular infliximab therapy for treatment-resistant temporomandibular joint arthritis in children: a retrospective study.Rheumatology.  52:554-559. 2013
2013 Shrinking lung syndrome as a manifestation of pleuritis: a new model based on pulmonary physiological studies.Journal of Rheumatology.  40:273-281. 2013
2012 Mechanisms involved in the p62-73 idiopeptide-modulated delay of lupus nephritis in SNF(1) mice.Lupus.  21:1552-1564. 2012
2012 Risk factors for temporomandibular joint arthritis in children with juvenile idiopathic arthritis.Journal of Rheumatology.  39:1880-1887. 2012
2012 Intra-articular corticosteroid injections to the temporomandibular joints are safe and appear to be effective therapy in children with juvenile idiopathic arthritis.Journal of Oral and Maxillofacial Surgery.  70:1802-1807. 2012
2012 Consensus treatment plans for new-onset systemic juvenile idiopathic arthritis.Arthritis Care and Research.  64:1001-1010. 2012
2012 17β-Estradiol (E-2) administration to male (NZB × SWR)F₁ mice results in increased Id(LN)F₁-reactive memory T-lymphocytes and accelerated glomerulonephritis.Lupus.  21:288-301. 2012
2012 MR enterography to evaluate sub-clinical intestinal inflammation in children with spondyloarthritis.Pediatric Rheumatology.  10:6. 2012
2012 IgA transglutaminase levels in children with Juvenile Idiopathic Arthritis.Annals of paediatric rheumatology.  1:31-35. 2012
2011 Fecal calprotectin in children with the enthesitis-related arthritis subtype of juvenile idiopathic arthritis.Journal of Rheumatology.  38:2274-2275. 2011
2011 Psoriatic juvenile idiopathic arthritis: a tale of two subgroups.Current Opinion in Rheumatology.  23:437-443. 2011
2011 Elevated IgG autoantibody production in oligoarticular juvenile idiopathic arthritis may predict a refractory course.Clinical and Experimental Rheumatology.  29:736-742. 2011
2011 Clinical comparison of early-onset psoriatic and non-psoriatic oligoarticular juvenile idiopathic arthritis.Clinical and Experimental Rheumatology.  29:582-588. 2011
2011 Interactions of the innate and adaptive arms of the immune system in the pathogenesis of spondyloarthritis.Clinical and Experimental Rheumatology.  29:322-330. 2011
2010 Validity of self-report of infections in a longitudinal cohort of patients with rheumatoid arthritis differs by source of report and infection severity.Journal of Clinical Epidemiology.  63:1358-1362. 2010
2010 Spondyloarthritis in a pediatric population: risk factors for sacroiliitis.Journal of Rheumatology.  37:2402-2408. 2010
2009 TNFalpha inhibitors may improve asthma symptoms: a case series of 12 patients with rheumatoid arthritis and asthma.JCR: Journal of Clinical Rheumatology.  15:198-200. 2009
2008 Biological therapies for the treatment of juvenile idiopathic arthritis: Lessons from the adult and pediatric experiences.Biologics : Targets & Therapy.  2:229-252. 2008
2008 Comparison of Vancouver and International League of Associations for rheumatology classification criteria for juvenile psoriatic arthritis.Arthritis and Rheumatism.  59:51-58. 2008
2007 Immunization with peptides derived from the idiotypic region of lupus-associated autoantibodies delays the development of lupus nephritis in the (SWR x NZB)F1 murine model.Journal of Autoimmunity.  29:30-37. 2007
2006 Patients with juvenile psoriatic arthritis comprise two distinct populations.Arthritis and Rheumatism.  54:3564-3572. 2006
2006 Subpopulations within juvenile psoriatic arthritis: a review of the literature.Clinical and Developmental Immunology.  13:377-380. 2006
2004 Incidence of occult bacteremia among highly febrile young children in the era of the pneumococcal conjugate vaccine: a study from a Children's Hospital Emergency Department and Urgent Care Center.Archives of Pediatrics and Adolescent Medicine.  158:671-675. 2004
2004 Efficacy of losartan in the treatment of erythrocytosis in a young adult with CRF.Pediatric Nephrology.  19:120-121. 2004
2003 Pheochromocytoma unmasked by imipramine in an 8-year-old girl.Pediatric Emergency Care.  19:174-177. 2003
2002 Molecular identification of pathogenetic IdLNF+1 autoantibody idiotypes derived from the NZBxSWR F1 model for systemic lupus erythematosus.Journal of Autoimmunity.  19:87-101. 2002
2002 Nephrolithiasis in a neonate with transient renal wasting of calcium and magnesium.Pediatric Nephrology.  17:386-389. 2002
2000 Systemic lupus erythematosus-messages from experimental models.Rheumatology.  39:18-27. 2000
1996 Circadian variations of urinary electrolyte concentrations in preterm and term infants.Journal of Pediatrics.  128:253-256. 1996

Chapter

Year Title Altmetric
2018 Inflammatory bowel disease.  251-274. 2018
2018 Juvenile idiopathic arthritis.  221-237. 2018
2018 Rheumatoid arthritis.  183-199. 2018
2018 The microbiome: Past, present, and future.  3-11. 2018
2018 The promise of personalized medicine.  465-474. 2018
2014 Juvenile Idiopathic Arthritis.  1950-1963. 2014
Extra-articular manifestations: inflammatory bowel disease

Education And Training

  • Doctor of Medicine, Syracuse University
  • Doctor of Philosophy in Immunology, Syracuse University
  • Full Name

  • Matthew Stoll